Emergent BioSolutions Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
04 Jun 24 | SellUS$61,100 | Kathryn Zoon | Individual | 10,000 | US$6.11 | |
29 May 24 | SellUS$8,436 | Kathryn Zoon | Individual | 1,830 | US$4.61 | |
21 May 24 | SellUS$6,294 | Kathryn Zoon | Individual | 1,089 | US$5.78 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Individual Insiders | 1,052,438 | 1.95% |
General Public | 24,245,714 | 44.9% |
Institutions | 28,721,810 | 53.2% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 4.3%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
3,666,234 | US$34.3m | 7.47% | no data | |||
3,166,246 | US$29.6m | -23.7% | no data | |||
1,968,784 | US$18.4m | -48.7% | no data | |||
993,418 | US$9.3m | -6.51% | no data | |||
946,302 | US$8.8m | 5.83% | 0.01% | |||
896,970 | US$8.4m | 3.05% | no data | |||
881,893 | US$8.2m | 241% | no data | |||
843,388 | US$7.9m | 19.4% | 0.03% | |||
827,796 | US$7.7m | 98.7% | 0.01% | |||
739,825 | US$6.9m | -4.62% | 0.03% | |||
649,501 | US$6.1m | 157% | no data | |||
575,400 | US$5.4m | -46.4% | 0.01% | |||
556,182 | US$5.2m | -50.4% | no data | |||
552,274 | US$5.2m | 39% | no data | |||
550,597 | US$5.1m | 0% | 2.38% | |||
542,813 | US$5.1m | 75.4% | 0.01% | |||
490,750 | US$4.6m | 298% | no data | |||
466,151 | US$4.4m | -0.84% | 2.52% | |||
457,908 | US$4.3m | -56.5% | 0.01% | |||
453,829 | US$4.2m | -1.69% | 0.12% | |||
446,540 | US$4.2m | -55.9% | 0.01% | |||
439,016 | US$4.1m | 109% | no data | |||
431,220 | US$4.0m | -3.66% | no data | |||
424,852 | US$4.0m | -49.4% | 0.01% | |||
346,354 | US$3.2m | 317% | no data |